Skip to main content
. 2025 Aug 11;19(1):476. doi: 10.1007/s11701-025-02427-w

Table 4.

Additional metrics used to evaluate learning curve (N=31)

Study Conversion to open access Reopening for bleeding Mortality ICU LOS (hours) Total hospital LOS (days)
Argenziano 2006 5/85 (6%) 0 0 35.0 5.1
Barac 2021 1/133 (1%) 0 0 NR 5
Bonaros 2006 0 0 0 26.0 8
Bonatti 2009 7/25 (28%) in phase 1, 2/ 25 (8%) in phase 2, 1/25 (4%) in phase 3, and 1/25 (4%) in phase 4

4/ 25 (16%) in phase 1,

3/25 (12%) in phase 2,

1/25 (4%) in phase 3, and

0/ 25 (0%) in phase 4

0 Phase 1 = 23, phase 2 = 20, phase 3 =20, phase 4 = 19 Phase 1 = 7, phase 2 = 6, phase 3 =5, phase 4 = 6
Bonatti 2004 2 3 0 24.0 8
Bonatti 2008 9% 5% 0 19 6
Cheng 2014 0 0 0 Quintile 1 = 27.2 ± 20, quintile 2 = 25.4 ± 21 quintile 3 = 26.4 ± 20 NR
ChitwoodJr 2005 0 2 1 NR 4.8
ChitwoodJr 2001 NR NR NR 19.3 3.5
Gao 2012 0 0 0 1.5 NR
Goodman 2017 NR 15 (3.7%) 0 32 to 28 to 24 hours (13% and 25% decrease) 5.2 to 4.5 to 3.8 days (13% and 27% decrease)
Gullu 2021 0 3.3% 0 23.2 to 19.5 NR
Hemli 2013 0 NR 0 NR NR
Isgro 2003 NR 0 NR NR NR
Jones 2005 3 0 2 (6%) NR

first 12: 5.7

last 12: 4.8

last 5: 3.4

Kakuta 2020 1 0 0 48 7
Kesavuori 2018 14 (9.9%) 2 (1.4%) 1 (0.7%) 24 7
Klepper 2022 5 (2.2%) NR 0 57.6 7.9
Masroor 2021 54 (4.5%) NR 10 (0.8%) NR 2 (0.2%)
Novick 2003 16 (17.8%) 2 0 28.8 4
Oehlinger 2007 1 0 0 20 7
Patrick 2021

Group 1 (n=465): 36 (7.7)

Group 2 (n=730): 18 (2.5)

Group 1 (n=465): 88 (18.9%)

Group 2 (n=730): 79 (10.8%)

Group 1 (n=465): 5

Group 2 (n=730): 5

NR NR
Ramzy 2014 1 7 0 NR 5.8
Sagbas 2006 2 2 NR 29.3 8.1
Schachner 2011 46 NR 2 (0.6%) 20 6
Schachner 2009 1 NR 0 NR 20

Seo 2019

(open vs robotic)

NR 4 vs. 3 7 vs. 1 144 vs. 84 9.9 vs. 6.5
VandenEynde 2021 NR NR 6 NR NR
Xiao 2014 0 0 0 29 12
Yaffee 2014 0 0 NR NR NR
Jonsson 2023 1.6% 22 (2.2%) 6 (0.6%) 37.7 4.43

Charland 2011 excluded